I believe that at Open Longevity we are executing the best possible strategy
to defeat aging. Can anyone present a more reasonable approach? If you can, I am ready to switch to your project. If not, let’s implement Open Longevity’s concepts together.
Ok, one more time — at openlongevity.io our main goal is to defeat aging and to extend people’s lives indefinitely.
Anti-aging field is huge and directly or indirectly it involves hundreds of laboratories, funds, start-ups and public initiatives.
We believe that the most important thing in life extension right now is to begin clinical trials (i.e. human trials) of the first, weak aging treatments. It is time we step away from laboratory experiments and start testing the technology on humans.
Enough scientific knowledge has been accumulated, clinical practice has been summarised, we even even made clinical experiments protocols (including the ones made by our team).
We want to conduct clinical research of aging therapies openly, not protecting them with patents. This will accelerate the whole process of creating aging medications and increase the level of expertise in the field.
In fact, this is exactly the goal of our project: competition of aging therapies clinical research conducted by volunteers.
The first step is introduction of aging diagnostics into clinical practice. We have already done the first step this year. Using scientific data we constructed a range of parameters, where people should try and keep their molecular — biological and functional indicators.
We now have 60 people who, at their own expense, passed aging diagnostics panel and about a thousand more interested in participating in the project. The number of people interested in aging diagnostics grows every month.
The second stage is clinical studies of diets.
The third one is studying combinations of pharmaceutical supplies. We have collected a database of substances which are potential geroprotectors already used in clinical practice.
The fourth one is gene therapy of aging.
The fifth one, carried out parallel to clinical studies, is automated delivery of information on the best strategies to personal aging deceleration.
A very important aspect of the project is to make cooperation between people with the same health problems and / or biological indicators possible. So that everyone can see how a particular therapy works on people with parameters similar to theirs. So that we can coordinate joint actions.
Of course, our project is going to use blockchain technology and Artificial Intelligence. In order to achieve all of the above we created Open Longevity.